VENCF (Vencanna Ventures) EPS without NRI: $0.00 (TTM As of Jan. 2026)


What is Vencanna Ventures EPS without NRI?

Vencanna Ventures VENCF +80.00% EPS without NRI is $0.00 as of Jan. 2026. The stock has 4 warning signs investors should review. Among 784 Drug Manufacturers companies, Vencanna Ventures ranks worse than 98.34% on this metric.

Vencanna Ventures's earnings per share without non-recurring items for the three months ended in Jan. 2026 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -81.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Vencanna Ventures's EPS without NRI or its related term are showing as below:

VENCF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -81.7   Med: 36.6   Max: 68.8
Current: -81.7

During the past 13 years, Vencanna Ventures's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 68.80% per year. The lowest was -81.70% per year. And the median was 36.60% per year.

VENCF's 3-Year EPS without NRI Growth Rate is ranked worse than
98.34% of 784 companies
in the Drug Manufacturers industry
Industry Median: 9.7 vs VENCF: -81.70

Vencanna Ventures's EPS (Diluted) for the three months ended in Jan. 2026 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00.

Vencanna Ventures's EPS (Basic) for the three months ended in Jan. 2026 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00.


Vencanna Ventures  (OTCPK:VENCF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Vencanna Ventures EPS without NRI Related Terms


Vencanna Ventures EPS without NRI Historical Data

* Premium members only.

The historical data trend for Vencanna Ventures's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vencanna Ventures EPS without NRI Chart

Vencanna Ventures Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 0.00 -0.01

Vencanna Ventures Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00

VENCF vs ZTS, UTHR: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vencanna Ventures PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Vencanna Ventures's PE Ratio without NRI falls into.



Vencanna Ventures EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.00 mean?
Vencanna Ventures (VENCF) has a EPS without NRI of $0.00 as of Jan. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Vencanna Ventures and its competitors. According to the industry distribution chart, Vencanna Ventures ranks #771 out of 784 companies in the Drug Manufacturers industry, placing it in the top 98.3%.
Is Vencanna Ventures' EPS without NRI too high?
Vencanna Ventures' current EPS without NRI is $0.00. Based on the distribution chart, Vencanna Ventures ranks #771 out of 784 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Vencanna Ventures' EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #771 out of 784 companies for EPS without NRI. This places Vencanna Ventures in the lower half of its industry. The industry median EPS without NRI is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.70, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current EPS without NRI is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current EPS without NRI of $0.00. The current EPS without NRI is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current EPS without NRI is $0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vencanna Ventures Business Description

Other Exchanges VENI:Canada
Address 622 5th Avenue SW, Suite 200, Calgary, AB, CAN, T2P 0M6
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.